National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant CD40-ligand
A recombinant therapeutic agent which is chemically identical to or similar to CD40-ligand. CD40-ligand, also known as CD40L/TRAP and CD154, is a type II membrane protein which binds to CD40, a cell surface receptor that belongs to the tumor necrosis factor receptor family; CD40 is expressed on B lymphocytes, monocytes, dendritic cells (DC), hematopoietic progenitors, endothelial cells and epithelial cells. Recombinant CD40-ligand may be used to activate DC ex vivo via CD40 binding; CD40-ligand-activated DC may provide or augment a protective antitumor immunity when administered in dendritic cell cancer vaccines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:CD154 antigen
gp39
gp39 cytokine
T-BAM
T-cell antigen gp39
TNF-related activation protein
TRAP ligand
Abbreviations:CD40L
rhu CD40L



Previous:recombinant adenovirus-hIFN-beta, recombinant adenovirus-interferon SCH 721015, recombinant adenovirus-L523S vaccine, recombinant adenovirus-p53 SCH-58500, recombinant bispecific single-chain antibody rM28
Next:recombinant dHER2 vaccine, recombinant flt3 ligand, recombinant fowlpox GM-CSF vaccine adjuvant, recombinant fowlpox-B7.1 vaccine, recombinant fowlpox-CEA(6D)/TRICOM vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov